Skip to content

Selection of anticoagulation/antiplate therapy regimen and efficacy analysis of patients with lower extremity intermuscular venous thrombosis after stroke

Research on anticoagulation regimens in patients with stroke in combination with muscular calf vein thrombosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500103283
Enrollment
Unknown
Registered
2025-05-27
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with stroke in combination with muscular calf vein thrombosis

Interventions

non-anticoagulant therapy group:None
Anticoagulant therapy group :None

Sponsors

Zhongshan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The presence of cerebral infarction or cerebral hemorrhage was determined by cranial CT or MRI examination, which meets the diagnostic criteria for stroke; 2. Patients with the first diagnosis of the presence of isolated lower extremity venous intermuscular thrombosis; 3. Patients who have previously signed an informed consent for biospecimen donation, agreeing to donate their samples and data for all medical research.

Exclusion criteria

Exclusion criteria: 1. Patients with combined proximal lower extremity deep vein thrombosis or thrombosis of popliteal, anterior tibial, posterior tibial, or peroneal veins; 2.Previous VTE or suspected PE; 3. Patients who require long-term anticoagulation for reasons other than combined atrial fibrillation.

Design outcomes

Primary

MeasureTime frame
Thrombosis outcome;

Secondary

MeasureTime frame
Safety analysis of anticoagulation therapy;

Countries

China

Contacts

Public ContactMingzhen Yang

Zhongshan Hospital Fudan University

yang.mingzhen@zs-hospital.sh.cn+86 183 1708 8163

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026